These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32052321)

  • 1. Cannabidiol treatment in an adolescent with multiple substance abuse, social anxiety and depression.
    Laczkovics C; Kothgassner OD; Felnhofer A; Klier CM
    Neuropsychiatr; 2021 Mar; 35(1):31-34. PubMed ID: 32052321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review.
    Hen-Shoval D; Weller A; Weizman A; Shoval G
    Int J Environ Res Public Health; 2022 Jan; 19(1):. PubMed ID: 35010782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiolytic Effects of Repeated Cannabidiol Treatment in Teenagers With Social Anxiety Disorders.
    Masataka N
    Front Psychol; 2019; 10():2466. PubMed ID: 31787910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age.
    Crippa JA; Guimarães FS; Campos AC; Zuardi AW
    Front Immunol; 2018; 9():2009. PubMed ID: 30298064
    [No Abstract]   [Full Text] [Related]  

  • 5. Cannabidiol and substance use disorder: Dream or reality.
    Karimi-Haghighi S; Razavi Y; Iezzi D; Scheyer AF; Manzoni O; Haghparast A
    Neuropharmacology; 2022 Apr; 207():108948. PubMed ID: 35032495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report.
    Crippa JA; Hallak JE; Machado-de-Sousa JP; Queiroz RH; Bergamaschi M; Chagas MH; Zuardi AW
    J Clin Pharm Ther; 2013 Apr; 38(2):162-4. PubMed ID: 23095052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.
    Nadulski T; Pragst F; Weinberg G; Roser P; Schnelle M; Fronk EM; Stadelmann AM
    Ther Drug Monit; 2005 Dec; 27(6):799-810. PubMed ID: 16306858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: CBD Cigarettes for Harm Reduction and Adjunctive Therapy in a Patient With Schizophrenia and Substance Use Disorder.
    Meyer M; Walter M; Borgwardt S; Scheidegger A; Lang E; Köck P
    Front Psychiatry; 2021; 12():712110. PubMed ID: 34366942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol (CBD) use in psychiatric disorders: A systematic review.
    Bonaccorso S; Ricciardi A; Zangani C; Chiappini S; Schifano F
    Neurotoxicology; 2019 Sep; 74():282-298. PubMed ID: 31412258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiol in the context of substance use disorder treatment: A systematic review.
    Paulus V; Billieux J; Benyamina A; Karila L
    Addict Behav; 2022 Sep; 132():107360. PubMed ID: 35580370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Substance use, affective problems and personality traits: test of two association models].
    Chakroun N; Doron J; Swendsen J
    Encephale; 2004; 30(6):564-9. PubMed ID: 15738859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol (CBD): Perspectives from Pinterest.
    Merten JW; Gordon BT; King JL; Pappas C
    Subst Use Misuse; 2020; 55(13):2213-2220. PubMed ID: 32715862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a role for cannabidiol in psychiatry?
    Khoury JM; Neves MCLD; Roque MAV; Queiroz DAB; Corrêa de Freitas AA; de Fátima Â; Moreira FA; Garcia FD
    World J Biol Psychiatry; 2019 Feb; 20(2):101-116. PubMed ID: 28112021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Cannabidiol on Psychiatric and Medical Conditions.
    Oberbarnscheidt T; Miller NS
    J Clin Med Res; 2020 Jul; 12(7):393-403. PubMed ID: 32655732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings.
    Elsaid S; Kloiber S; Le Foll B
    Prog Mol Biol Transl Sci; 2019; 167():25-75. PubMed ID: 31601406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of cannabis, cannabidiol and synthetic cannabinoid use with mental health in UK adolescents.
    Hotham J; Cannings-John R; Moore L; Hawkins J; Bonell C; Hickman M; Zammit S; Hines LA; Adara L; Townson J; White J
    Br J Psychiatry; 2023 Oct; 223(4):478-484. PubMed ID: 37485911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic.
    Rapin L; Gamaoun R; El Hage C; Arboleda MF; Prosk E
    J Cannabis Res; 2021 Jun; 3(1):19. PubMed ID: 34162446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic role of Cannabidiol in mental health: a systematic review.
    Khan R; Naveed S; Mian N; Fida A; Raafey MA; Aedma KK
    J Cannabis Res; 2020 Jan; 2(1):2. PubMed ID: 33526132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Use of Δ9-THC and Cannabidiol: Evaluation of a New Extraction Procedure for the Preparation of Cannabis-based Olive Oil.
    Morini L; Porro G; Liso M; Groppi A
    Curr Pharm Biotechnol; 2017; 18(10):828-833. PubMed ID: 29189144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.